Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Head & Neck 1

Conditions

Head and Neck Neoplasms 20Squamous Cell Carcinoma of Head and Neck 11Mouth Neoplasms 6Lung Neoplasms 5Head and Neck Carcinoma 5Oropharyngeal Neoplasms 4Laryngeal Neoplasms 4Stomatitis 3Xerostomia 2Hypopharyngeal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Ulcer 1Tonsillar Neoplasms 1Tongue Neoplasms 1Tobacco Use 1Speech 1Recurrence 1Parotid Neoplasms 1Parathyroid Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mucositis 1Maxillary Sinus Neoplasms 1Lymphedema 1Localized Head and Neck Carcinoma 1Hyperparathyroidism, Primary 1Hypercalcemia 1Fibrosis 1Esophageal Neoplasms 1

Interventions

Low-Level Light Therapy 2carbohydrate-deficient transferrin 1Tocopherols 1Standard of Care 1Restraint, Physical 1Pravastatin 1Physical Therapy Modalities 1Pharmaceutical Preparations 1Pentoxifylline 1Moxibustion 1Methods 1Ketoprofen 1Indocyanine Green 1Independent Medical Evaluation 1High-Energy Shock Waves 1Drug Delivery Systems 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphedema × Standard of Care × Head & Neck × Clear all
NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

M.D. Anderson Cancer Center

Phase 2 Recruiting
250 enrolled
Head & Neck

Fibrosis, Head and Neck Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡